BOSTON, May 9, 2017 /PRNewswire/ -- Burns & Levinson announced today that three highly accomplished life sciences attorneys – Daniel W. Clarke, Ph.D., Christopher R. Cowles, Ph.D., and Richard B. Emmons, Ph.D. – have joined the firm as partners in its Life Sciences and Intellectual Property (IP) Groups. Together, the team brings over three decades of combined experience representing innovative clients in the life sciences and technology sectors on intellectual property matters. Their expertise expands the depth and breadth of the intellectual property practice at Burns & Levinson and allows Drs. Clarke, Cowles, and Emmons to provide clients with seasoned advice and unparalleled service. They were previously with Mintz Levin in Boston.
"Our life sciences and intellectual property practices continue to grow in response to increasing demand for the client-focused and results-oriented legal services that our firm provides," said David P. Rosenblatt, managing partner at Burns & Levinson. "We are committed to strategically growing our Intellectual Property Group into one of the nation's top IP practices, and are always looking to add exceptional talent to our world-class team. Dan, Chris, and Richard are impressive attorneys who will be a great asset to our high profile life sciences clients."
Dr. Clarke counsels clients in strategic patent procurement, IP due diligence, and worldwide prosecution in the area of biotechnology and the life sciences. He works with a broad range of clients – from small biotech start-ups and academic institutions, to mid-sized and large biotechnology and pharmaceutical companies – in the fields of cellular and molecular biology, oncology, immunology, microbiology, and virology, among others. Dr. Clarke earned his B.A. from the University of Texas in 2001, his Ph.D. in molecular microbiology from the University of Texas Southwestern Medical Center in 2006, and his J.D., with distinction, from Suffolk University in 2011. In 2016, he was recognized as a Rising Star by Massachusetts Super Lawyers and as a Future Leader by the Greater Boston Chamber of Commerce.
Dr. Cowles possesses law firm and in-house experience in biotechnology patent preparation and prosecution, domestic and international IP portfolio management, and IP due diligence. His areas of expertise include oligonucleotide therapeutics, oncology, diagnostics, antibody, microbiology, virology, cell biology, and genomic technologies. Dr. Cowles earned his B.A., magna cum laude, in biochemistry and economics from Rice University in 1992, his Ph.D. in biomedical sciences from the University of California – San Diego in 1998, and his J.D., cum laude, from Suffolk University in 2008. He performed post-doctoral research at the Whitehead Institute/MIT as a Damon Runyon fellow, and has been recognized as a Rising Star in 2016 by Massachusetts Super Lawyers.
Dr. Emmons counsels corporate and institutional clients in the preparation and prosecution of U.S. and foreign patents in the life sciences, medical device, and mechanical art areas. He assists clients with IP due diligence, IP licensing, and patentability, infringement, validity, and freedom-to-operate analyses. His areas of expertise include cell and molecular biology, genetics, and developmental biology. Dr. Emmons earned his B.A. in ecology from the College of the Atlantic in 1992, his Ph.D. in developmental biology from Washington University School of Medicine in 2000, and his J.D. from Suffolk University in 2012. He also performed post-doctoral research in the Department of Genetics at the Harvard Medical School. He has been recognized as a Rising Star (2014-2016) by Massachusetts Super Lawyers.
The legal and scientific prowess of Drs. Clarke, Cowles, and Emmons further enhances Burns' existing team of high-caliber IP and business attorneys who advise life sciences companies throughout their life cycle – from technology and product licensing, patent and trademark procurement and enforcement, and strategic partnering and acquisitions to public and private financings, cross-border transactions, and export regulation compliance. The firm represents life sciences companies and entrepreneurs around the globe in diverse industries including biotechnology, clinical diagnostics, health care, medical devices, medical equipment, and pharmaceuticals, as well as academic institutions and research organizations.
About Burns & Levinson LLP
At Burns & Levinson, we provide high-level, client-centric and results-oriented legal services to our regional, national and international clients. We are a full-service law firm with over 125 lawyers in Boston, Providence and other regional offices. The firm has grown steadily and strategically throughout the years and has become a premier law firm. Our areas of expertise include: business/finance, business litigation/dispute resolution, divorce/family law, venture capital/emerging companies, employment, estate planning, government investigations, intellectual property, M&A/private equity, probate/trust litigation, and real estate. We partner with our clients to solve their business and personal legal issues in a collaborative, creative, and cost-effective way. For more information, visit Burns & Levinson at www.burnslev.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/burns--levinson-expands-intellectual-property-practice-with-addition-of-three-life-sciences-partners-300454214.html
SOURCE Burns & Levinson LLP